Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| G1 Therapeutics | 19 | 3 | 3 | 2 | €2.07 | €10.54 | 409.836% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €5.88 | €11.00 | 87.138% |
| Biocryst Pharmaceuticals | 9 | 0 | 0 | 0 | €5.99 | €11.05 | 84.366% |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €16.30 | €12.06 | -25.988% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €2.50 | €12.21 | 388.436% |
| MacroGenics Inc. | 13 | 0 | 0 | 0 | €4.20 | €12.42 | 196.108% |
| Syros Pharmaceuticals Inc. | 6 | 1 | 0 | 0 | €5.40 | €13.60 | 151.806% |
| Rigel Pharmaceutical Inc. | 12 | 0 | 2 | 0 | €0.91 | €13.78 | 1420.022% |
| Novavax Inc. | 5 | 1 | 0 | 1 | €13.12 | €17.59 | 34.086% |
| Amicus Therapeutics Inc. | 7 | 0 | 1 | 0 | €9.15 | €17.64 | 92.762% |
| Verastem Inc. | 11 | 0 | 4 | 0 | €2.90 | €19.20 | 562.066% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €4.60 | €19.50 | 323.880% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 3 | 0 | €14.58 | €24.13 | 65.579% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.40 | €24.97 | 6.723% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.58 | €26.01 | 26.367% |
| Dynavax Technologies Corp | 2 | 0 | 0 | 0 | €10.70 | €26.95 | 151.984% |
| EyePoint Pharmaceuticals Inc. | 20 | 1 | 2 | 0 | €8.10 | €27.83 | 243.423% |
| TG Therapeutics Inc. | 22 | 4 | 0 | 0 | €16.97 | €28.06 | 65.416% |
| Anika Therapeutics | 5 | 0 | 0 | 0 | €24.20 | €28.29 | 16.904% |
| Innoviva Inc. | 4 | 0 | 1 | 0 | €14.80 | €30.00 | 102.703% |
| Xencor Inc. | 14 | 1 | 4 | 0 | €18.30 | €31.70 | 73.205% |
| Acadia Pharmaceuticals | 28 | 1 | 0 | 0 | €14.79 | €31.78 | 114.903% |
| Abeona Therapeutics Inc. | 4 | 1 | 0 | 0 | €4.04 | €33.73 | 734.861% |
| Corcept Therapeutics Inc. | 14 | 0 | 3 | 0 | €28.27 | €37.08 | 31.157% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.49 | €40.66 | 53.519% |